These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 9019170)
41. Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Brower M; Carney DN; Oie HK; Gazdar AF; Minna JD Cancer Res; 1986 Feb; 46(2):798-806. PubMed ID: 3940644 [TBL] [Abstract][Full Text] [Related]
42. Neoplastic progression of rat tracheal epithelial cells is associated with a reduction in the number of growth factors required for clonal proliferation in culture. Thomassen DG In Vitro Cell Dev Biol Anim; 1993 Jun; 29A(6):498-504. PubMed ID: 8331033 [TBL] [Abstract][Full Text] [Related]
43. Stimulation of proliferation and maturation of rat astroblasts in serum-free culture by an astroglial growth factor. Pettmann B; Weibel M; Daune G; Sensenbrenner M; Labourdette G J Neurosci Res; 1982; 8(2-3):463-76. PubMed ID: 7154125 [TBL] [Abstract][Full Text] [Related]
44. Properties and biological activities of thioredoxins. Powis G; Montfort WR Annu Rev Pharmacol Toxicol; 2001; 41():261-95. PubMed ID: 11264458 [TBL] [Abstract][Full Text] [Related]
45. Thioredoxin and thioredoxin reductase expression in thyroid cancer depends on tumour aggressiveness. Lincoln DT; Al-Yatama F; Mohammed FM; Al-Banaw AG; Al-Bader M; Burge M; Sinowatz F; Singal PK Anticancer Res; 2010 Mar; 30(3):767-75. PubMed ID: 20392995 [TBL] [Abstract][Full Text] [Related]
46. High-density lipoproteins and the proliferation of human tumor cells maintained on extracellular matrix-coated dishes and exposed to defined medium. Gospodarowicz D; Lui GM; Gonzalez R Cancer Res; 1982 Sep; 42(9):3704-13. PubMed ID: 7049362 [TBL] [Abstract][Full Text] [Related]
47. Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73-->Ser mutation. Gasdaska JR; Kirkpatrick DL; Montfort W; Kuperus M; Hill SR; Berggren M; Powis G Biochem Pharmacol; 1996 Dec; 52(11):1741-7. PubMed ID: 8986137 [TBL] [Abstract][Full Text] [Related]
48. Quantification of redox conditions in the nucleus. Go YM; Pohl J; Jones DP Methods Mol Biol; 2009; 464():303-17. PubMed ID: 18951192 [TBL] [Abstract][Full Text] [Related]
49. Site-directed mutagenesis of Lys36 in human thioredoxin: the highly conserved residue affects reduction rates and growth stimulation but is not essential for the redox protein's biochemical or biological properties. Oblong JE; Berggren M; Gasdaska PY; Hill SR; Powis G Biochemistry; 1995 Mar; 34(10):3319-24. PubMed ID: 7880827 [TBL] [Abstract][Full Text] [Related]
50. Ability of endothelial cells to condition culture medium. Gajdusek CM; Schwartz SM J Cell Physiol; 1982 Jan; 110(1):35-42. PubMed ID: 7068765 [TBL] [Abstract][Full Text] [Related]
51. Thioredoxin redox control of cell growth and death and the effects of inhibitors. Powis G; Kirkpatrick DL; Angulo M; Baker A Chem Biol Interact; 1998 Apr; 111-112():23-34. PubMed ID: 9679540 [TBL] [Abstract][Full Text] [Related]
52. Complementation of cell and serum growth factors during proliferation of tumour cells in semisolid medium. Cherepantseva E; Shevlyagin VJ; Altstein AD Folia Biol (Praha); 1986; 32(6):414-23. PubMed ID: 3803626 [TBL] [Abstract][Full Text] [Related]
53. Apparent heterogeneity in the response of quiescent swiss 3T3 cells to serum growth factors: implications for the transition probability model and parallels with "cellular senescence" and "competence". Brooks RF; Richmond FN; Riddle PN; Richmond KM J Cell Physiol; 1984 Nov; 121(2):341-50. PubMed ID: 6333428 [TBL] [Abstract][Full Text] [Related]
54. Detection of membrane associated thioredoxin on human cell lines. Wollman EE; Kahan A; Fradelizi D Biochem Biophys Res Commun; 1997 Jan; 230(3):602-6. PubMed ID: 9015370 [TBL] [Abstract][Full Text] [Related]
55. [Effect of proteins from bovine milk serum on the multiplication of human cancerous cells]. Bourtourault M; Buléon R; Sampérez S; Jouan P C R Seances Soc Biol Fil; 1991; 185(5):319-23. PubMed ID: 1806191 [TBL] [Abstract][Full Text] [Related]
56. Age-related and carcinogen-induced alterations of the extracellular growth factor requirements for cell proliferation in vitro. Swierenga SH; Whitfield JF; Boynton AL J Cell Physiol; 1978 Feb; 94(2):171-80. PubMed ID: 621217 [TBL] [Abstract][Full Text] [Related]
57. Early effects of medium change in cultured cells: evidences for the existence of negative modulators of cell proliferation. Lage A; Rodríguez R; Valdés D; Lombardero J Neoplasma; 1983; 30(6):701-10. PubMed ID: 6656967 [TBL] [Abstract][Full Text] [Related]
58. Platelets as a source of growth-promoting factor(s) for tumor cells. Hara Y; Steiner M; Baldini MG Cancer Res; 1980 Apr; 40(4):1212-6. PubMed ID: 7357550 [TBL] [Abstract][Full Text] [Related]
59. [Presence of supposed growth factors in a serum fraction with a molecular weight of the components from 100,000 to 200,000 D]. Kruman II; Ostapenko NF; Gavriliuk BK; Marchenko LL Tsitologiia; 1982 Mar; 24(3):345-8. PubMed ID: 7080200 [TBL] [Abstract][Full Text] [Related]
60. [The characteristics of the stimulation of the proliferation of cultured chick embryo cells during reseeding]. Gasparian GG; Grigorian RM Tsitol Genet; 1989; 23(5):30-4. PubMed ID: 2688224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]